Loading organizations...
§ Venture Capital · Chicago, IL, USA
Key people at Satter Investment Management.
Satter Investment Management was founded in 2012 by Muneer A. Satter (Founder).
Satter Investment Management LLC is an investment advisory firm, strategically deploying capital within the life sciences and technology sectors. The firm identifies and cultivates high-potential companies, providing essential investment to accelerate innovation and growth. Its expertise lies in recognizing disruptive solutions and partnering with enterprises at the forefront of scientific and technological advancement.
Muneer A. Satter founded Satter Investment Management in 2012, following a distinguished career at Goldman Sachs. His extensive background in global finance provided the core insight to establish a firm dedicated to high-growth ventures, leveraging his deep understanding of market dynamics and emerging innovations.
The firm serves investors seeking exposure to significant growth potential in life sciences and technology. Satter Investment Management’s vision centers on identifying and supporting enterprises poised for substantial impact through discovery. The company aims to be a catalyst for progress, facilitating development of solutions addressing challenges and redefining industry standards.
Satter Investment Management was founded in 2012 by Muneer A. Satter (Founder).
Key people at Satter Investment Management.
Satter Investment Management has 5 tracked investments across 2 companies. The latest tracked deal is $75.0M Series C in Annexon Biosciences in December 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2018 | Annexon Biosciences | $75.0M Series C | Ricky SUN | James Barrett, Adage Capital Management, Blackstone, NEA, Novartis, Surveyor Capital |
| Jun 1, 2016 | Annexon Biosciences | $44.0M Series B | Frank Torti | James Barrett, Clarus, Correlation Ventures, Novartis |
| Dec 15, 2014 | Annexon Biosciences | $34.0M Series A | DRX Capital | Clarus Ventures |
| Apr 23, 2014 | Aerpio Pharmaceuticals | $22.0M Other Equity | Chau Khuong | Athenian Venture Partners, DRX Capital, Kearny Venture Partners, Triathlon Medical Ventures, Venture Investors |
| Apr 1, 2014 | Aerpio Pharmaceuticals | $22.0M Series C | OrbiMed | Cincy Tech, Athenian Venture Partners, DRX Capital, Kearny Venture Partners, Triathlon Medical Ventures, Venture Investors |